Merck will reduce its workforce by approximately 6,000 employees in “some areas of our global workforce,” the New Jersey ...

Merck said on Tuesday it was extending its pause on Gardasil shipments to China until at least the end of 2025 due to ...

Thousands of Medicare recipients will face higher costs for expensive cancer drugs following passage of two provisions in the One Big Beautiful Bill Act, signed by President Donald Trump in July, The ...

Shipments to China are now paused through the end of 2025, dragging global sales of the HPV vaccine down 55% last quarter.

Merck (NYSE:MRK) is cutting $3 billion from its annual expenses as it prepares for generic competition to its blockbuster ...

Merck & Co. is slashing $3 billion from its annual spending as it braces for off-brand competition to its cancer drug ...

BEIJING— Merck MRK -1.70% & Co.’s immunotherapy cancer drug Keytruda is finding its way into China as the first imported drug approved for use under a pilot program on the resort island of ...

Keytruda, which is given by infusion, belongs to a newer class of cancer drugs called immune checkpoint inhibitors. They work by releasing a particular "brake" on the immune system, which allows ...

Keytruda is used for the treatment of different types of cancers, including lung, head & neck, and melanoma among others. It has become the most important drug for Merck, given its contribution to ...

Merck MRK 1.73% & Co.’s new cancer drug Keytruda improved the survival odds of patients with the skin cancer melanoma compared with Bristol-Myers Squibb Co.’s BMY 1.00% Yervoy, in the first ...

A large clinical trial shows that Keytruda is a more effective initial treatment than chemotherapy, the current standard of care, for two-thirds of patients with the most common type of lung cancer.

The first large clinical trial of Keytruda in men with advanced prostate cancer has shown 'spectacular' results, but only in a small number of patients, who researchers suspect have specific DNA ...